Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

With many of the Magnificent 7 stocks reporting earnings the week of October 28, investors’ attention was on technology ...

A multidisciplinary team of experts in lung cancer screening and implementation science from the UCLA Health Jonsson Comprehensive Cancer Center, the David Geffen School of Medicine at UCLA and the ...

Reports of drug-related supply-chain issues were 40 percent less likely to result in drug shortages in Canada versus the United States, according to a new study.

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, myasthenia gravis and other conditions traced to misdirected immune response.

Relesium combines the scientifically backed benefits of chicken egg powder and bovine colostrum, offering an all-natural solution for companies aiming to address digestive discomfort, such as nausea, ...

In this article, we will take a look at the 10 Best Pharma Stocks To Buy Right Now.

Deane received honoraria from Bristol Myers Squibb, Thermo Fisher, and Werfen and grant funding from Janssen Research and Development and Gilead Sciences. Mankia received grant support from Gilead, ...

Khalil had no disclosures and no external study funding was noted. One co-investigator reported stock options in Allurion, ...

Sales of blood cancer drug Revlimid, which is now facing generic competition, dropped 11% to $1.41 billion in the quarter, ...